MedPath

A Comparison of Effectiveness of Amitriptyline and Topiramate in the Treatment of Painful Diabetic Neuropathy

Not Applicable
Completed
Conditions
Diabetic neuropathy.
Autonomic neuropathy in endocrine and metabolic diseases
Registration Number
IRCT201210113565N6
Lead Sponsor
Endocrine Research Centre of Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion criteria :patients with diabetes mellitus ; both genders ; between 18-80 years of age ; under anti hyperglycemic agents therapy ;with diabetic peripheral neuropathy syptoms in the form of pain and paresthesia in rest for at least 1 month. Exclusion criteria : persons with any important clinical disease; unstable clinical or psychologic disease ; other neurupathic causes ;renal dysfunction ;liver disease ; epilepsy ;psychiatric disease ;uncontroled HTN ;malignancy ;opiate addiction ;anti epileptic ,anti depressant , topical anti pain or opioid tretmant ;pregnant and lactating women ; need to change treatment.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response to treatment. Timepoint: 3 month. Method of measurement: History and Physical Exam , EMG/NCV if needed.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath